PMC:7299399 / 99057-100116
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 325-329 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T2 | 813-817 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T259 | 848-854 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T260 | 940-948 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 108-114 | http://purl.obolibrary.org/obo/NCBITaxon_9005 | denotes | Turkey |
| T2 | 325-329 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T3 | 349-352 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T4 | 443-446 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T5 | 598-604 | http://purl.obolibrary.org/obo/NCBITaxon_9005 | denotes | Turkey |
| T6 | 769-780 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | is focusing |
| T7 | 813-817 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T8 | 952-958 | http://purl.obolibrary.org/obo/NCBITaxon_9005 | denotes | Turkey |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1047 | 763-768 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T718 | 872-880 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T44215 | 911-915 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T44164 | 1053-1058 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T53 | 848-854 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T432 | 0-116 | Sentence | denotes | Açelya Yilmazer is an Associate Professor at the Department of Biomedical Engineering at Ankara University (Turkey). |
| T433 | 117-238 | Sentence | denotes | In 2012, she obtained her Ph.D. in the Nanomedicine Lab based in the School of Pharmacy, University College London (Prof. |
| T434 | 239-241 | Sentence | denotes | K. |
| T435 | 242-254 | Sentence | denotes | Kostarelos). |
| T436 | 255-344 | Sentence | denotes | Later, she continued her postdoctoral work in the same lab on in vivo cell reprogramming. |
| T437 | 345-438 | Sentence | denotes | She has extensive experience on in vitro and in vivo preclinical evaluation of nanomaterials. |
| T438 | 439-544 | Sentence | denotes | She has coordinated the genotoxicity related work package of the Graphene Flagera project “G-IMMUNOMICS”. |
| T439 | 545-749 | Sentence | denotes | She was selected as the “Best Young Investigator” in Turkey by the Turkish Society of Medical Biology and Genetics in 2013 and given the “Young Scientist Award” by the Turkish Academy of Sciences in 2019. |
| T440 | 750-881 | Sentence | denotes | Her research group is focusing on the use of nanomaterials and cell reprogramming technologies in cancer and regenerative medicine. |
| T441 | 882-1059 | Sentence | denotes | She is currently involved in drug repurposing project for COVID-19 in Turkey, and she is coordinating the workpackage related to preclinical investigation of the screened drugs. |